TrialThe Journal of investigative dermatology2022

A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation.

Michael S Garshick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.